title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
54 Biggest Movers From Yesterday,20220420T094334,https://www.benzinga.com/news/22/04/26706319/54-biggest-movers-from-yesterday,CADL,0.069124,Neutral,0.006355
38 Stocks Moving In Tuesday's Mid-Day Session,20220419T161631,https://www.benzinga.com/news/22/04/26694580/38-stocks-moving-in-tuesdays-mid-day-session,CADL,0.101132,Neutral,0.000883
Top 5 NASDAQ Biotech Stocks,20240710T211500,https://investingnews.com/daily/life-science-investing/biotech-investing/top-nasdaq-biotech-stocks/,CADL,0.035714,Neutral,0.105262
"Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday - Amprius Technologies  ( NYSE:AMPX ) , ALFI  ( NASDAQ:ALF ) ",20221024T093702,https://www.benzinga.com/news/22/10/29374553/why-huntington-bancshares-shares-surged-around-10-here-are-72-biggest-movers-from-friday,CADL,0.062761,Somewhat-Bullish,0.271494
"Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Broadcom  ( NASDAQ:AVGO ) , Actuate Therapeutics  ( NASDAQ:ACTU ) ",20241213T103018,https://www.benzinga.com/24/12/42479777/why-rh-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket,CADL,0.151064,Neutral,-0.048815
"Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - African Agriculture Hldgs  ( NASDAQ:AAGR ) , Achieve Life Sciences  ( NASDAQ:ACHV ) ",20231212T182222,https://www.benzinga.com/news/23/12/36203637/why-johnson-controls-international-shares-are-trading-lower-by-over-6-here-are-other-stocks-moving-i,CADL,0.098862,Neutral,-0.00791
"GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing - Corbus Pharmaceuticals  ( NASDAQ:CRBP ) , Candel Therapeutics  ( NASDAQ:CADL ) ",20240718T173638,https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39845426/genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-test,CADL,0.171485,Neutral,0.0
"Oncolytic Virus Immunotherapy Market Expected to Reach USD 572.2 million by 2031, Expanding at a 21.1% CAGR | Transparency Market Research, Inc.",20240221T110718,https://www.benzinga.com/pressreleases/24/02/g37231570/oncolytic-virus-immunotherapy-market-expected-to-reach-usd-572-2-million-by-2031-expanding-at-a-21,CADL,0.075161,Neutral,0.121248
